Upload

Loading icon Loading...

This video is unavailable.

Study hopes to provide answers to chemo fog

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like Vanderbilt Health News's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike Vanderbilt Health News's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add Vanderbilt Health News's video to your playlist.

Uploaded on Mar 3, 2008

It's a life-saving therapy, but scientists are learning that a persistent problem surfaces in many chemotherapy patients. The problem is chemo brain or chemo fog. Researchers say as many as 30 percent of chemotherapy patients suffer from chemo fog causing mild to moderate cognitive brain impairment. With the help of funding from well-known cancer survivor and athlete Lance Armstrong, researchers at Vanderbilt Medical Center in Nashville, Tennessee, have started the first-ever study hoping to clear some chemo fog. Barb Cramer has the story.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to